Paul Hutsell Maupin

Title: Paul Hutsell Maupin: Innovator in Disease Detection

Introduction

Paul Hutsell Maupin is a notable inventor based in San Diego, CA. He has made significant contributions to the field of medical diagnostics, particularly in the detection of disease conditions associated with elevated levels of aspartate aminotransferase (AST). His innovative approach has the potential to improve patient outcomes through more accurate disease assessment.

Latest Patents

Maupin holds a patent for a one-step test for aspartate aminotransferase. This novel assay kit and method are designed for the detection and determination of the severity of disease conditions linked to elevated AST levels. The method involves a reaction between AST and cysteine sulfinic acid (CSA) substrate, utilizing a sulfite-reactive dye compound that is largely nonreactive with AST or CSA. The resulting sulfite ion provides a calorimetric indication of AST levels, which can be correlated to predetermined stages of disease. This innovation represents a significant advancement in the field of medical diagnostics.

Career Highlights

Maupin is currently associated with Xytronyx, Inc., where he continues to develop and refine diagnostic technologies. His work focuses on creating efficient and effective methods for disease detection, which can lead to timely interventions and improved patient care.

Collaborations

[This section has been skipped due to space constraints.]

Conclusion

Paul Hutsell Maupin's contributions to medical diagnostics through his innovative patent for detecting aspartate aminotransferase levels highlight his role as a key inventor in the field. His work has the potential to significantly impact disease assessment and patient management.